Doris Wong Sing Ee - Feb 26, 2025 Form 3 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Datuk Dr. Doris Wong Sing Ee
Stock symbol
CYCC
Transactions as of
Feb 26, 2025
Transactions value $
$0
Form type
3
Date filed
2/28/2025, 11:32 AM
Previous filing
Dec 12, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYCC Common Stock 195M Feb 26, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were purchased in a private transaction pursuant to a certain Securities Purchase Agreement, between the Reporting Person and a certain shareholder of the Issuer, for the aggregate purchase price of $6.3M.